Literature DB >> 9488384

Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells.

U Fluckiger1, K F Jones, V A Fischetti.   

Abstract

The M protein is one of the most important virulence factors of group A streptococci (Streptococcus pyogenes) and may play an important role in the first steps of streptococcal infection. Since acute pharyngitis is a frequently occurring infectious disease caused by these bacteria, we wished to know whether antibodies to the M protein or other surface components inhibit adherence and internalization of streptococci to pharyngeal cells. We investigated the role of whole human secretory immunoglobulin A (sIgA), M6 protein-specific sIgA, and M6 protein-specific serum IgG in the inhibition of streptococcal adherence and internalization to cultured human pharyngeal cells. S. pyogenes D471, which produces a type 6 M protein (M+), and its isogenic M-negative (M-) derivative JRS75 were tested. Purified whole sIgA, M protein-specific sIgA, and sIgA preabsorbed with M protein were able to decrease significantly the adherence of streptococci to pharyngeal cells. Purified IgG against the M6 protein did not diminish the attachment of streptococci to the pharyngeal cells but did reduce internalization. Thus, our data suggest that secretory IgA may play a key role in preventing streptococcal infection at mucosal surfaces by blocking adherence while affinity-purified anti-M protein-specific IgG blocks epitopes responsible for invasion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488384      PMCID: PMC108004          DOI: 10.1128/IAI.66.3.974-979.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Respiratory epithelial cell invasion by group B streptococci.

Authors:  C E Rubens; S Smith; M Hulse; E Y Chi; G van Belle
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

2.  A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12.

Authors:  R R Isberg; S Falkow
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

3.  Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells.

Authors:  S R Talay; P Valentin-Weigand; P G Jerlström; K N Timmis; G S Chhatwal
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

4.  Adherence pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells.

Authors:  M Alkan; I Ofek; E H Beachey
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

5.  Expression of protein F, the fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains promotes their adherence to respiratory epithelial cells.

Authors:  E Hanski; P A Horwitz; M G Caparon
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

6.  Adherence of group A streptococci to fibronectin on oral epithelial cells.

Authors:  W A Simpson; E H Beachey
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.

Authors:  D Bessen; V A Fischetti
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.

Authors:  D Bessen; V A Fischetti
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

9.  A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity.

Authors:  V Pancholi; V A Fischetti
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

10.  Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein.

Authors:  V A Fischetti; K F Jones; B N Manjula; J R Scott
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  12 in total

1.  Surface expression of the conserved C repeat region of streptococcal M6 protein within the Pip bacteriophage receptor of Lactococcus lactis.

Authors:  B L Geller; N Wade; T D Gilberts; D E Hruby; R Johanson; L Topisirovic
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

2.  Analysis of factors affecting surface expression and immunogenicity of recombinant proteins expressed by gram-positive commensal vectors.

Authors:  Tové C Bolken; Christine A Franke; Kevin F Jones; Richard H Bell; Ryan M Swanson; David S King; Vincent A Fischetti; Dennis E Hruby
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  A globally disseminated M1 subclone of group A streptococci differs from other subclones by 70 kilobases of prophage DNA and capacity for high-frequency intracellular invasion.

Authors:  P P Cleary; D LaPenta; R Vessela; H Lam; D Cue
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  Long-term survival of Streptococcus pyogenes in rich media is pH-dependent.

Authors:  Dragutin J Savic; William M McShan
Journal:  Microbiology (Reading)       Date:  2012-02-23       Impact factor: 2.777

Review 5.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

6.  Vaccine strategies to prevent rheumatic fever.

Authors:  E R Brandt; M F Good
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

7.  A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.

Authors:  Aniela Wozniak; Patricia García; Enrique A Geoffroy; Daniel B Aguirre; Samantha A González; Victoria A Sarno; James B Dale; Francisco J Salazar-Echegarai; Andrea Vera; Susan M Bueno; Alexis M Kalergis
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

8.  Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins.

Authors:  Sean D Reid; Alison G Montgomery; Jovanka M Voyich; Frank R DeLeo; Benfang Lei; Robin M Ireland; Nicole M Green; Mengyao Liu; Slawomir Lukomski; James M Musser
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.

Authors:  Praveen Mannam; Kevin F Jones; Bruce L Geller
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Production of stabilized virulence factor-negative variants by group A streptococci during stationary phase.

Authors:  B A Leonard; M Woischnik; A Podbielski
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.